Probiotec Limited (AU:PBP) has released an update.
Probiotec Limited has distributed a supplementary scheme booklet to its shareholders, detailing the proposed acquisition by PYFA Australia Pty Ltd, a subsidiary of PT Pyridam Farma TBK. Shareholders have been advised to read the booklet thoroughly before the upcoming vote on the arrangement, with the company’s Independent Board Committee and CEO Wesley Stringer unanimously recommending a vote in favor of the scheme. The booklet contains essential information for shareholders, who are encouraged to consult professional advisors if in doubt.
For further insights into AU:PBP stock, check out TipRanks’ Stock Analysis page.
